1
|
Brook C, Burdon J, Trembath P. Comment on 'Cough syncope as a cause of motor vehicle crash: fatal distraction?'. Intern Med J 2023; 53:1295-1296. [PMID: 37474457 DOI: 10.1111/imj.16163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Accepted: 04/08/2023] [Indexed: 07/22/2023]
Affiliation(s)
- Chris Brook
- Universidad de La Laguna (ULL), La Laguna, Tenerife, Spain
| | - Jonathan Burdon
- Consultant Respiratory Physician, East Melbourne, Victoria, Australia
| | - Peter Trembath
- Epworth Richmond Hospital, Melbourne, Victoria, Australia
| |
Collapse
|
2
|
Song Y, Hong J, Bao Z, Ye J, Zheng X, Zou S. Cough syncope due to laryngeal herpes zoster successfully managed by pregabalin. Arch Med Sci 2023; 19:298-301. [PMID: 36817652 PMCID: PMC9897074 DOI: 10.5114/aoms/158551] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/29/2022] [Accepted: 12/26/2022] [Indexed: 01/19/2023] Open
Affiliation(s)
- Yingfang Song
- Department of Pulmonary and Critical Care Medicine, 900 Hospital of Joint Logistics Support Forth, Fuzhou, China
- Dongfang Hospital, School of Medicine, Xiamen University, China
- Fuzong Clinical College of Fujian Medical University, Fuzhou, China
| | - Jingfang Hong
- Dongfang Hospital, School of Medicine, Xiamen University, China
- Fuzong Clinical College of Fujian Medical University, Fuzhou, China
- Departments of Neurosurgery, 900 Hospital of Joint Logistics Support Forth, Fuzhou, China
| | - Zhenming Bao
- Department of Pulmonary and Critical Care Medicine, 900 Hospital of Joint Logistics Support Forth, Fuzhou, China
- Dongfang Hospital, School of Medicine, Xiamen University, China
- Fuzong Clinical College of Fujian Medical University, Fuzhou, China
| | - Jia Ye
- Department of Pulmonary and Critical Care Medicine, 900 Hospital of Joint Logistics Support Forth, Fuzhou, China
- Dongfang Hospital, School of Medicine, Xiamen University, China
- Fuzong Clinical College of Fujian Medical University, Fuzhou, China
| | - Xi Zheng
- Department of Pulmonary and Critical Care Medicine, 900 Hospital of Joint Logistics Support Forth, Fuzhou, China
- Department of Pulmonary and Critical Care Medicine, People’s Hospital of Tiantai County, Tiantai, China
| | - Shumei Zou
- Department of Pulmonary and Critical Care Medicine, 900 Hospital of Joint Logistics Support Forth, Fuzhou, China
- Dongfang Hospital, School of Medicine, Xiamen University, China
- Fuzong Clinical College of Fujian Medical University, Fuzhou, China
| |
Collapse
|
3
|
Nikkho SM, Richter MJ, Shen E, Abman SH, Antoniou K, Chung J, Fernandes P, Hassoun P, Lazarus HM, Olschewski H, Piccari L, Psotka M, Saggar R, Shlobin OA, Stockbridge N, Vitulo P, Vizza CD, Wort SJ, Nathan SD. Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension. Pulm Circ 2022; 12:e12127. [PMID: 36016668 PMCID: PMC9395696 DOI: 10.1002/pul2.12127] [Citation(s) in RCA: 30] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/15/2022] [Revised: 07/18/2022] [Accepted: 08/09/2022] [Indexed: 11/18/2022] Open
Abstract
Pulmonary hypertension (PH) has been linked to worse outcomes in chronic lung diseases. The presence of PH in the setting of underlying Interstitial Lung Disease (ILD) is strongly associated with decreased exercise and functional capacity, an increased risk of hospitalizations and death. Examining the scope of this issue and its impact on patients is the first step in trying to define a roadmap to facilitate and encourage future research in this area. The aim of our working group is to strengthen the communities understanding of PH due to lung diseases and to improve the care and quality of life of affected patients. This introductory statement provides a broad overview and lays the foundation for further in-depth papers on specific topics pertaining to PH-ILD.
Collapse
Affiliation(s)
| | - Manuel J. Richter
- Department of Internal Medicine Pulmonary Hypertension DivisionUniversities of Giessen and Marburg Lung Center (UGMLC)GiessenGermany
| | - Eric Shen
- Global Medical AffairsUnited Therapeutics CorporationSilver SpringMarylandUSA
| | - Steven H. Abman
- School of Medicine and Children's HospitalUniversity of Colorado—Anschutz Medical CampusAuroraColoradoUSA
| | - Katerina Antoniou
- Department of Thoracic MedicineUniversity of Crete School of MedicineHeraklionCreteGreece
| | - Jonathan Chung
- Department of RadiologyThe University of Chicago MedicineChicagoIllinoisUSA
| | - Peter Fernandes
- Regulatory, Safety and Quality DepartmentBellerophon Therapeutics IncWarrenNew JerseyUSA
| | - Paul Hassoun
- Department of Medicine, Division of Pulmonary and Critical Care MedicineJohns Hopkins UniversityBaltimoreMarylandUSA
| | | | - Horst Olschewski
- Division of Pulmonology, Department of Internal MedicineMedical University of GrazGrazSteiermarkAustria
| | - Lucilla Piccari
- Department of Pulmonary MedicineHospital del Mar, Pulmonary Hypertension UnitBarcelonaCatalunyaSpain
| | - Mitchell Psotka
- Inova Heart and Vascular InstituteFalls ChurchVirginiaUSA
- Division of Cardiology and NephrologyFood and Drug AdministrationSilver SpringMarylandUSA
| | - Rajan Saggar
- Lung & Heart‐Lung Transplant and Pulmonary Hypertension ProgramsUniversity of California Los Angeles David Geffen School of MedicineLos AngelesCaliforniaUSA
| | - Oksana A. Shlobin
- Advanced Lung Disease and Transplant ProgramInova Heart and Vascular InstituteFalls ChurchVirginiaUSA
| | - Norman Stockbridge
- Division of Cardiology and NephrologyUS Food and Drug AdministrationSilver SpringMarylandUSA
| | - Patrizio Vitulo
- Therapies, Department of Pulmonary MedicineIRCCS Mediterranean Institute for Transplantation and Advanced SpecializedPalermoSiciliaItaly
| | | | - Stephen J. Wort
- National Pulmonary Hypertension Service at Royal Brompton HospitalLondonUK
- National Heart and Lung Institute, Imperial CollegeLondonUK
| | - Steven D. Nathan
- Advanced Lung Disease and Transplant ProgramInova Heart and Vascular InstituteFalls ChurchVirginiaUSA
| |
Collapse
|